Wikidata entity: Q417997
C₂₄H₂₁F₂NO₃ (P274)
Quantities
| P4250 | defined daily dose | 10 |
| P2067 | mass | 409.14895 |
| P3780 | active ingredient in | ... | Q47522344 (Zetia) | Zetia |
| P233 | canonical SMILES | String | C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O | ??? |
| P373 | Commons category | String | Ezetimibe | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | C1=CC(=CC=C1[C@@H]2[C@H](C(=O)N2C3=CC=C(C=C3)F)CC[C@@H](C4=CC=C(C=C4)F)O)O | ??? |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284310 (LiverTox toxicity likelihood category C) | LiverTox toxicity likelihood category C |
| P2175 | medical condition treated | ... | Q1827605 (lipedema) | lipedema |
| P2175 | medical condition treated | ... | Q2711291 (familial hypercholesterolemia) | familial hypercholesterolemia |
| P2175 | medical condition treated | ... | Q55785266 (rare dyslipidemia) | rare dyslipidemia |
| P129 | physically interacts with | ... | Q903909 (NPC1 like intracellular cholesterol transporter 1) | NPC1 like intracellular cholesterol transporter 1 |
| P3489 | pregnancy category | ... | Q3679261 (Australian pregnancy category C) | Australian pregnancy category C |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P636 | route of administration | ... | Q285166 (oral administration) | oral administration |
| P769 | significant drug interaction | ... | Q419724 (fenofibrate) | fenofibrate |
| P279 | subclass of | ... | Q27163509 ((3R,4S)-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone) | (3R,4S)-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone |
| P2868 | subject has role | ... | Q50429847 (anticholesteremic agents) | anticholesteremic agents |
| P2868 | subject has role | ... | Q50430353 (lipid regulating agents) | lipid regulating agents |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | ezetimibe | ??? |
Why not click here or view trends?
log id: 2062015